Skip to main content

Option Care Health Value Stock - Dividend - Research Selection

Bioscrip

ISIN: US68404L2016 , WKN: A2PZEY

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield%
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



DescriptionData
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

BioScrip, Inc. provides infusion solutions in the United States. It engages in the preparation, delivery, administration, and clinical monitoring of pharmaceutical treatments that are administered to a patient through intravenous, subcutaneous, intramuscular, intra-spinal, and enteral methods. The company is primarily involved in the intravenous administration of medications to treat a range of acute and chronic conditions, such as infections, nutritional deficiencies, immunologic and neurologic disorders, cancer, pain, and palliative care. It also offers home nursing products and services to patients suffering from chronic and acute medical conditions. The company offers its services at patient\'s homes, outpatient clinics, nursing facilities, physician\'s offices, and ambulatory infusion centers. It markets and sells its products and services through sales and marketing representatives, and payor relationships. The company was founded in 1993 and is based in Denver, Colorado.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


Option Care Health Insiders Placed Bullish Bets Worth US$3.22m

2024-07-02
Multiple insiders secured a larger position in Option Care Health, Inc. ( NASDAQ:OPCH ) shares over the last 12 months...

Did Option Care Health, Inc. (OPCH) Have a Solid Performance in Q1?

2024-06-27
We recently compiled a list of the 10 Best Healthcare Stocks to Buy Under $50. In this article, we are going to take a look at where Option Care Health, Inc. (NASDAQ:OPCH) stands against the other healthcare stocks under $50. If interested, you can also read our recent article on the 10 Best Healthcare Stocks […]

The 3 Highest-Rated Medical Stocks You Can Buy Today

2024-06-27
The medical field is a non-negotiable aspect of society. Advanced healthcare is required to combat existing diseases and protect ourselves from new ones. Constant innovation in the medical field is a net positive for the world, increasing life expectancies, improving living conditions and saving countless lives. On a more prosaic but no less important note, investors who want to participate in advancing medicine and healthcare can look into highly rated medical stocks. In the U.S. alone, nationa

Zacks.com featured highlights include J.Jill, Option Care Health and Amphenol

2024-06-11
J.Jill, Option Care Health and Amphenol have been highlighted in this Screen of The Week article.

3 Stocks Backed by High Efficiency To Boost Portfolio Returns

2024-06-10
Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.

Buy These 3 Beaten-Down MedTech Stocks for a Turnaround Soon

2024-06-07
Investing in beaten-down stocks like OPCH, LNTH and HOLX can be profitable for investors in the long term.

Analysts Are Bullish on These Healthcare Stocks: Option Care Health (OPCH), Gilead Sciences (GILD)

2024-06-06
Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.

Option Care (OPCH) Upgraded to Strong Buy: Here's Why

2024-06-03
Option Care (OPCH) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

Option Care Health: A Deep Dive Into Its Market Dominance

2024-05-31
Option Care Health is poised to benefit from the shift to home-based health and the growing specialty pharmaceuticals market. Learn more about OPCH stock here.

3 Highly Ranked Medical Stocks Added to the Zacks Strong Buy List

2024-05-28
Considering the stretched premiums many groundbreaking healthcare companies can command, these medical stocks are worthy of investors' interest given their attractive P/E valuations and the positive trend of earnings estimate revisions.